ClinicalTrials.gg
RecruitingNCT07451405Updated Mar 5, 2026

The Effect of Oscillation and Lung Expansion (OLE) Therapy in Prolonged Mechanical Ventilated Patients With Atelectasis Evaluated in Multiple Methods

An interventional study of High frequency chest wall oscillation or other airway clearance therapy and Oscillation and lung expansion in Atelectasis, sponsored by Capital Medical University. Recruiting at 2 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-05.

Sponsored by Capital Medical University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 24 studies in Pulmonary Atelectasis with a site in China — 13 open to participants now, 14 under way, none of them phase 3. Pulmonary Atelectasis · China.

Planned enrollment
14th of 21
60 · median 90
Started
2026
with 4 others
No phase
19 of 24
12 open now
Primary completion
2026-04
later than 6 of 13 live
Registered
21st of 24
by date
Lead sponsor
1 of 24
Capital Medical University

Among the 24 studies in Pulmonary Atelectasis with a site in China, this one is the 14th largest by planned enrollment of the 21 interventional ones that give a count, is one of 5 that started in 2026, is one of 19 with no phase, reaches primary completion later than 6 of the 13 other live ones, and was the 21st registered.

Pulmonary Atelectasis

378 studies on the registry are indexed under Pulmonary Atelectasis; 91 are open to participants now.

Browse Pulmonary Atelectasis studies →

Open to participants now

13 of the 24 studies in Pulmonary Atelectasis with a site in China are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 51 Pulmonary Atelectasis studies recruiting now, 20 (39%) set no upper age limit and 23 (45%) stop at 75 or younger; 24 take children under 18; 2 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Pulmonary Atelectasis with a site in China, or all of them as a file.
02

Study summary

High frequency chest wall oscillation (HFCWO) is currently one of the most common and widespread mechanical airway clearance techniques (ACTs) in clinical practice in China. As an external airway oscillation technique, it has been proven in previous clinical practices that it can help clear secretions by vibrating the chest wall, loosening the secretions adhering to the airway walls and promoting ciliary movement, thereby improving lung ventilation and re-expansion. However, there are still some groups of patients for whom this technique is not suitable in clinical practice, such as those who are uncomfortable with the oscillation, have damaged skin on the chest and back, have unstable rib fractures, or have poorly positioned tracheostomy tubes. In recent years, integrating multiple techniques into a single treatment has become a trend. Among them, oscillation and lung expansion (OLE) combines continuous positive airway pressure (CPAP), continuous high-frequency oscillation (CHFO), and nebulization, which can effectively clear airway secretions and promote lung re-expansion. Currently, only a few studies have confirmed that OLE has a positive impact on improving respiratory function in patients with acute respiratory failure, severe burns, and after lung surgery.

This study aims to further compare the effects of the above two mechanical ACTs on improving lung ventilation and re-expansion by electrical impedance tomography (EIT), and optimize the clinical practice of physical therapists.

03

Conditions studied

  • Atelectasis

Browse trials for

Keywords

  • oscillation and lung expansion
  • high frequency chest wall
  • electrical impedance tomography
  • Atelectasis
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years old
  • The following characteristics of high mucus secretion in the airway occur along with pulmonary infection: coughing up a large amount of white sticky phlegm, yellow phlegm or yellow purulent phlegm; Phlegm sounds can be heard in the lungs. The frequency of sputum aspiration is higher than once every 4 hours
  • Tracheotomy time ≥7 days
  • Vital signs are stable.

Exclusion criteria

Exclusion Criteria:

  • Hemodynamic instability
  • Inhaled oxygen concentration (FiO2) > 60%
  • Untreated pneumothorax
  • Patients who have undergone total pneumonectomy
  • Hemoptysis
  • Pulmonary bullae, etc.
  • Patients with delirium and restlessness
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Placebo comparator
    Coventional therapy group

    This group conducted casual treatment and airway clearance (except oscillation an lung expansion therapy)

    Other: High frequency chest wall oscillation or other airway clearance therapy

  • Experimental
    OLE group

    This group conducted casual treatment and oscillation an lung expansion on daily therapy

    Other: High frequency chest wall oscillation or other airway clearance therapy · Other: Oscillation and lung expansion

Interventions

  • OtherHigh frequency chest wall oscillation or other airway clearance therapy

    High frequency chest wall oscillation (HFCWO) is an external airway oscillation technique, it has been proven in previous clinical practices that it can help clear secretions by vibrating the chest wall, loosening the secretions adhering to the airway walls and promoting ciliary movement, thereby improving lung ventilation and re-expansion. We will give the patients HFCWO twice a day and each time we will give them 15HZ as frequency and 20mins as time. Other therapies are postural drainage, manual vibration...

  • OtherOscillation and lung expansion

    oscillation and lung expansion (OLE) combines continuous positive airway pressure (CPAP), continuous high-frequency oscillation (CHFO), and nebulization, which can effectively clear airway secretions and promote lung re-expansion. The OLE will be given to the patients twice a day as well, and each time 10mins therapy with 2.5mins CPAP and 2.5mins CHFO cirsularly.

06

What researchers measure

Primary outcomes

  1. Change in Atelectatic Lung Area on Chest CT

    Atelectatic lung area will be quantified on chest computed tomography (CT) images by a blinded radiologist using imaging analysis software. The primary outcome is the change in atelectatic lung area from baseline to 10 days post-treatment. The unit of the measures is Square centimeters (cm²)

    Time frame: Baseline and 10 days post-treatment

Secondary outcomes

  1. Ventilation distribution on Electrical impedance tomography (EIT) evaluation

    electrical impedance tomography will be used to evaluated the ventilation : Select a large, medium, or small electrode belt according to the patient's body size and place it on the chest (at the level of the 4th-5th intercostal spaces). Ensure that the belt position remains consistent for each measurement. Inject current through the electrode belt and measure the corresponding voltage to reconstruct the intrathoracic impedance distribution and display the corresponding images. Continuously record for 90 seconds and store the EIT data. Global inhomogeneity(GI) value describe the ventilation dstribute, the value is more closer to 0.25, is better.

    Time frame: at admission and 3days/7days/10 days after treatment

  2. Lung Ultrasound score(LUS)

    Lung aeration will be assessed using the Lung Ultrasound Score (LUS).Scan 12 areas to get a relevent score for degrees of lung aeration of each area according the patterns that we got on the lung ultrasound. Each lung region will be scored according to standard criteria, and the total score will be calculated. The outcome measure is the change in total LUS from baseline to 10 days post-treatment. Score ranged from 0 to 36.Higher scores indicate worse lung aeration.

    Time frame: at admission and 10 days after treatment

  3. Oxygenation index

    Oxygenation index is measured by fingertip blood oxygen and is expressed as a percentage.

    Time frame: at admission and 10 days after treatment

  4. the score on Modified Borg dyspnea scale

    a number that reflect the degree of dyspnea on patient reporting according to the Modified Borg dyspnea scale

    Time frame: at admission and 10 days after treatment

  5. The Clinical Pulmonary Infection Score

    The Clinical Pulmonary Infection Score (CPIS) is a pulmonary infection assessment system formed by integrating multiple clinical indicators such as body temperature, white blood cell count, and oxygenation index,scaled from 0 to 12, the higher scores, the higher risk of infection.

    Time frame: from enrollment to 2 weeks after the treatment

  6. daily cost

    Daily cost in HDU was calculated by a speciallist nurse and is expressd as Chinese yuan

    Time frame: in 10 days after admission

07

Study locations

1 of 2 sites recruiting
  • Respiratory rehabilitation center
    Beijing, Beijing Municipality 100144, China
    Recruiting
    • Shuo Chen · Contact010-56981092
  • Shuo Chen
    Beijing, China
    Completed

    Not enrolling at this site.

08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2026; primary completion for Apr 2026, 0 months later.

Of 155 non-industry interventional studies with no phase under Pulmonary Atelectasis, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 0 months is below that.

Counting every sponsor, half of 157 studies reached it within 11 months; a quarter within 5 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 30, 2025
First posted
Mar 5, 2026
StartEst.
Mar 15, 2026
Primary completionEst.
Apr 1, 2026
CompletionEst.
Oct 1, 2026
Last update
Mar 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07451405
Responsible party
Shuo Chen (Physical therapy, Capital Medical University) — Principal investigator
First posted
Mar 5, 2026
Start date
Mar 15, 2026 (estimated)
Primary completion
Apr 1, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Mar 5, 2026

Study contacts

Shuo Chen
Contact
983340122@qq.com
+86 13521362894

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion